NAV
₹518.1042
as of 17 Jun 2026
Expense Ratio
—
see scheme documents
Viewing Direct · Growth
Lumpsum returns (CAGR)
- 1Y
- +7.55%
- 3Y
- +18.99%
- 5Y
- +17.63%
- Since Inception
- +13.15%
SIP returns (XIRR)
- 1Y
- +8.97%
- 3Y
- +11.60%
- 5Y
- +16.28%
- Since Inception
- +15.28%
Performance Comparison
Thinking about Tata Mid Cap Fund · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Fund Details
Fund HouseTata Mutual Fund
CategoryMid Cap
Launch Date01 Jul 1994
AMFI Code119178
Transaction facts
Min. Lumpsum₹5,000
Min. SIP₹100
Exit LoadOn or before 30 days from the date of allotment 0.50% After 30 days from the date of allotment NIL
Available transactions
PurchaseSIPRedeemSWPSwitchSTPDemat
Portfolio holdings
as of 31 Mar 2026
portfolio shared with Tata Mid Cap Fund Regular Plan- Growth Option
Holding% NAV
- 1Mankind Pharma Ltd3.21%
- 2Federal Bank Ltd3.12%
- 3Indian Bank3.11%
- 4Max Financial Services Ltd2.84%
- 5Upl Ltd2.62%
- 6Indus Towers Ltd2.60%
- 7Marico Ltd2.58%
- 8Indusind Bank Ltd2.56%
- 9Glenmark Pharmaceuticals Ltd2.56%
- 10Au Small Finance Bank Ltd2.53%
Rows per page· 64 total
Page 1/7
Investment Objective
Tata Mid Cap Fund · Direct · Growth seeks to generate long-term capital appreciation by investing in mid-cap companies — ranked 101st to 250th by market capitalisation. These companies offer a balance of growth potential and relative stability, making them suitable for investors with moderate to high risk appetite.
About This Fund
Tata Mid Cap Fund · Direct · Growth is a Mid Cap mutual fund offered by Tata Mutual Fund. The fund has been operational for over 31 years.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations